MyAverix Finance
US · Healthcare
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV)
Biotechnology
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $782.20M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TRAXV
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — FAQ
What is First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's market cap?
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a reported market cap of $782.20M (data as of 2026-05-22).
What is TRAXV's P/E ratio?
The price-to-earnings (P/E) ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) is 25.00 (data as of 2026-05-22).
Does First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued pay a dividend?
Dividend yield is not available in the current snapshot for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV). Check the MyAverix Finance app for the latest dividend data.
What sector is First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued in?
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TRAXV listed on?
TRAXV is listed on US.
What is First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's net margin?
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.